ÀÓ»ó ÇöÀåÀÇ AI ½ÃÀå : ¿¹Ãø(2025-2030³â)
AI in Clinical Settings Market - Forecasts from 2025 to 2030
»óǰÄÚµå : 1627576
¸®¼­Ä¡»ç : Knowledge Sourcing Intelligence
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 140 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,715,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,550 £Ü 6,583,000
PDF (Multiple User License) help
PDF º¸°í¼­¸¦ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÀÓ»ó ÇöÀåÀÇ AI ½ÃÀåÀº CAGR 37.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÓ»ó ÇöÀåÀÇ AI ½ÃÀåÀº ȯÀÚ °á°ú ¹× Áø´Ü È¿À²¼º Çâ»ó¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö°í, ÀÇ·á ºÐ¾ßÀÇ ¹æ´ëÇÑ µ¥ÀÌÅÍ·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ ÀÇ·á ¿µ»ó ºÐ¼®, ÀǾàǰ °³¹ß, Á¤¹Ð Åõ¾à, Áø´Ü ¹× Ä¡·á °ü¸®, ÀÓ»ó ¿µ»ó ó¸® µî ´Ù¾çÇÑ Ãø¸é¿¡¼­ ÀǷḦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ AI´Â ÇÊ¿äÇÑ Ä¡·á¿¡ ÀûÇÕÇÑ È¯ÀÚÀÇ Æ¯¼ºÀ» ÆÄ¾ÇÇÏ¿© ÀûÀýÇÑ Ä¡·á ó¹æÀ» ÃËÁøÇϰí, AI Áö¿ø ½Ã½ºÅÛÀº ½Ç¿ëÀûÀÎ ¿ëµµ·Î ÀÓ»ó ÀÇ»ç°áÁ¤ Áö¿øÀ» Á¦°øÇÏ¿© ÀÇ·á Àü¹®°¡°¡ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

ÀÓ»ó ÇöÀåÀÇ AI ½ÃÀå Ȱ¼ºÈ­ ¿äÀÎ

ÀÇ·áºñ »ó½ÂÀº Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÇ ¹®Á¦ÀÔ´Ï´Ù. ÀÌ´Â °í·ÉÈ­, ±â¼ú Çõ½Å, °ü¸®ÀÇ º¹À⼺, ¾àÁ¦ºñ, ±¹¹æ ÀÇ·á, ÀÇ·á Á¦°øÀÇ ºñÈ¿À²¼º µî ´Ù¾çÇÑ ¿äÀΰú °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ÀÌ¿¡ ´õÇØ »ç¿ìµð Á¤ºÎ´Â 'ºñÀü 2030'¿¡ µû¶ó 650¾ï ´Þ·¯ ÀÌ»óÀ» ÅõÀÚÇÏ¿© ÀÇ·á ÀÎÇÁ¶ó¸¦ Á¤ºñÇϰí, º¸Çè ¹× ÀÇ·á ¼­ºñ½ºÀÇ ±¸Á¶Á¶Á¤°ú ¹Î¿µÈ­¸¦ ÃßÁøÇϸç, Àü±¹¿¡ 21°³ÀÇ '°Ç°­ Ŭ·¯½ºÅÍ'¸¦ ¼³¸³Çϰí, e-Çコ ¼­ºñ½ºÀÇ °¡¿ë¼ºÀ» ³ôÀÏ °èȹÀÔ´Ï´Ù. ¸¶Âù°¡Áö·Î ¹Î°£ ºÎ¹®ÀÇ Âü¿©µµ 2030³â±îÁö 40°³¿¡¼­ 65°³·Î ´Ã¸®´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ 290°³ÀÇ º´¿ø°ú 2300°³ÀÇ ÀÏÂ÷ÀÇ·á¼¾ÅͰ¡ ¹Î¿µÈ­µÉ ¿¹Á¤À̸ç, ÀÌ´Â È®´ëµÇ´Â »ç¿ìµðÀÇ ÇコÄÉ¾î ½ÃÀå¿¡ ÅõÀÚÇÏ´Â ¹Ì±¹ ±â¾÷µé¿¡°Ô Å« ºñÁî´Ï½º ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù.

Àα¸ °í·ÉÈ­¿¡ µû¶ó ¸¸¼ºÁúȯ ¹× ³ëÈ­ °ü·Ã ÁúȯÀ» Áß½ÉÀ¸·Î ÇコÄÉ¾î ¼­ºñ½º ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä Áõ°¡´Â ÀÇ·á ÀÚ¿øÀ» °í°¥½ÃŰ´Â µ¿½Ã¿¡ ºñ¿ëÀ» »ó½Â½Ãŵ´Ï´Ù. ¶ÇÇÑ, ÀǷẸÇè û±¸, û±¸, ±ÔÁ¦ Áؼö µîÀÇ °ü¸® ºñ¿ëÀÌ ºñ¿ë ºÎ´ãÀ» Áõ°¡½Ãŵ´Ï´Ù.

ÀÓ»ó ÇöÀåÀÇ AI ½ÃÀåÀÇ Áö¸®Àû Àü¸Á:

Áö¿ªº°·Î´Â ºÏ¹Ì, ³²¹Ì, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾çÀ¸·Î ³ª´¹´Ï´Ù. ºÏ¹ÌÀÇ ÀÓ»ó AI ½ÃÀåÀº °­·ÂÇÑ ÇコÄɾî ÀÎÇÁ¶ó, ÇコÄÉ¾î ±â¼ú ¹× ¿¬±¸¿¡ ´ëÇÑ ´ë±Ô¸ð ÅõÀÚ, AI Áö¿ø ¼Ö·ç¼ÇÀÇ Çõ½Å°ú äÅÃÀ» ÃËÁøÇÏ´Â ¿ì¼öÇÑ ±ÔÁ¦ ȯ°æÀ¸·Î ÀÎÇØ Å©°Ô °ßÀεǰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ÀÇ»çÇùȸ¿¡ µû¸£¸é, ¹Ì±¹Àº 2022³â 4Á¶ 4,644¾ï ´Þ·¯ÀÇ ÀÇ·áºñ¸¦ ÁöÃâÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ Áß º´¿ø(30.4%), ÀÇ»ç ¼­ºñ½º(14.5%), ÀÓ»ó ¼­ºñ½º(5.3%), ÀçÅÃÀÇ·á(3%), ¿ä¾ç¿ø(4.3%), 󹿾à(9.1%), ±âŸ °³ÀÎ ÀÇ·á(16.5%), °Ç°­ º¸Çè ¼øºñ¿ë(6.3%), Á¤ºÎ °ü¸®(1,2%), Á¤ºÎ °øÁߺ¸°Ç Ȱµ¿(4.7%), ÅõÀÚ(4.9%) ¼øÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó ÇöÀåÀÇ AI ½ÃÀåÀº ºü¸£°Ô ¼ºÀåÇÏ´Â ÇコÄÉ¾î ºÎ¹®, Àα¸ Áõ°¡, ÀÇ·áºñ »ó½Â µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í AI µµÀÔÀ» Áö¿øÇÏ´Â Á¤ºÎÀÇ ³ë·Â°ú Á¤Ã¥ÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Àεµ¿¡¼­´Â 2016³â¿¡ 3,7,416°ÇÀÇ Àü¸³¼±¾Ï ȯÀÚ°¡ º¸°íµÇ¾ú°í, 2020³â¿¡´Â 4,1,532°ÇÀ¸·Î Áõ°¡ÇßÀ¸¸ç, 2025³â¿¡´Â 4,7,000°Ç ÀÌ»óÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ¼öÄ¡´Â ±¹³» Àüü ¾Ï ȯÀÚÀÇ ¾à 3%¿¡ ÇØ´çÇÕ´Ï´Ù. ¶ÇÇÑ, Àεµ¿¡¼­ Àü¸³¼±¾ÏÀÌ ¹ß»ýÇÏ´Â Æò±Õ ¿¬·ÉÀº 69.7¼¼ÀÔ´Ï´Ù. ¶ÇÇÑ, °¡Ã³ºÐ ¼ÒµæÀÇ Áõ°¡¿Í ÀÇ·áÁø°ú ȯÀÚµé »çÀÌ¿¡¼­ AIÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ÀÌ Áö¿ªÀÇ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¸¦ ±¸¸ÅÇØ¾ß ÇÏ´Â ÀÌÀ¯

¾î¶² ¿ëµµ·Î »ç¿ëµÇ´Â°¡?

»ê¾÷ ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÀÔ Àü·«, Áö¸®Àû È®Àå, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× ¿µÇâ, ½ÅÁ¦Ç° °³¹ß, °æÀïÀÇ ¿µÇâ

Á¶»ç ¹üÀ§

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

Á¦5Àå ÀÓ»ó ÇöÀåÀÇ AI ½ÃÀå : ±â¼úº°

Á¦6Àå ÀÓ»ó ÇöÀåÀÇ AI ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦7Àå ÀÓ»ó ÇöÀåÀÇ AI ½ÃÀå : Áö¿ªº°

Á¦8Àå °æÀï ȯ°æ°ú ºÐ¼®

Á¦9Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The AI in clinical settings market is anticipated to grow at a CAGR of 37.5%.

The AI in clinical settings market is growing significantly due to the enhanced requirements for improving patient outcomes and diagnostic efficiency and the large volume of data in health care.

It is also transforming health care from different fronts, such as medical image analysis, drug development, precision medication, diagnostic and treatment administration, and clinical image processing.

Moreover, AI promotes prescribing the right treatment by identifying patient characteristics to suit the required treatment. AI-aided systems also bring clinical decision support for practical uses, enabling healthcare professionals to arrive at decisions.

AI in the clinical settings market drivers:

The high cost of health care is a global problem for the healthcare system. These are associated with various factors such as the aging population, technological innovation, administrative complexities, cost of drugs, defensive medicine, and healthcare delivery inefficiency. In addition to this, the Saudi Arabian government intends to invest more than $65 billion under Vision 2030 to build its healthcare infrastructure, restructure and privatize insurance and health services, establish 21 "health clusters" nationwide, and increase the availability of e-health services. Similarly, private sector participation is aiming to increase from 40% to 65% by 2030. This would entail the privatization of 290 hospitals and 2300 primary health centers, thus creating considerable business opportunities for American companies investing in Saudi Arabia's expanding healthcare market.

With the aging population, demand for healthcare services expands, mainly in chronic diseases and age-related conditions. This increase in demand can strain healthcare resources while raising costs. Moreover, administrative costs such as healthcare insurance claims, billing, and regulatory compliance will increase the cost burden.

AI in clinical settings market geographical outlook:

Geography-wise, the market of AI in clinical settings is divided into North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The North American AI in clinical settings market is largely driven by a strong healthcare infrastructure, large-scale investment in healthcare technology and research, and an excellent regulatory environment that fosters innovation and adoption of AI-enabled solutions. According to the American Medical Association, the United States spent $4,464.4 billion on health care in 2022 which was divided into different segments out of which hospital care accounted for 30.4% share, followed by physician service (14.5%), clinical services (5.3%), home health care (3%), nursing care facilities (4.3%), prescription drugs (9.1%), other personal health care (16.5%), the net cost of health insurance (6.3%), government administration (1,2%), government public health activities (4.7%), and investment (4.9%).

On the other hand, several factors drive the Asia Pacific AI in the clinical settings market, including a rapidly growing healthcare sector, a large population, and rising healthcare costs. The increasing prevalence of chronic diseases and government initiatives and policies supporting AI adoption are accelerating market growth. For instance, India reported 37,416 cases of prostate cancer in 2016, and by 2020, that number had risen to 41,532 cases. By 2025, the incidence of prostate cancer is predicted to rise to over 47,000 cases. This figure represents approximately 3% of all cancer cases in the nation. Additionally, in India, the average age at which prostate cancer occurs is 69.7 years. Moreover, rising disposable incomes and growing awareness of AI's benefits among healthcare providers and patients are contributing to the regional market expansion.

Reasons for buying this report:-

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

The AI in clinical settings market is segmented and analyzed as follows:

By Technology

By End-User

By Geography

TABLE OF CONTENTS

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. AI IN CLINICAL SETTINGS MARKET BY TECHNOLOGY

6. AI IN CLINICAL SETTINGS MARKET BY END-USER

7. AI IN CLINICAL SETTINGS MARKET BY GEOGRAPHY

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

9. COMPANY PROFILES

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â